Stock data
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO) reported revenue of US$10.00M and net income of -US$377.74M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$10.00M | — | -US$383.06M | -US$377.74M | — |
| 2024 | US$5.00M | — | -US$163.89M | -US$156.99M | — |
| 2023 | US$50.00M | — | -US$37.15M | -US$37.12M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.00M | -US$111.46M | — |
| 2026-03-31 | — | -US$80.99M | — |
| 2025-12-31 | US$0.00M | -US$240.44M | — |
| 2025-09-30 | US$0.00M | -US$51.50M | — |
| 2025-06-30 | US$0.00M | -US$52.22M | — |
| 2025-03-31 | US$10.00M | -US$33.57M | — |
| 2024-12-31 | — | -US$52.60M | — |
| 2024-09-30 | US$0.00M | -US$38.61M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.